VPI-2690B
Product Specifications
Target
Integrin|||TGF-beta/Smad
Related Pathways
Stem Cells|||Cytoskeletal Signaling
Bioactivity
VPI-2690B is a human-derived monoclonal antibody (mAb) that targets Integrin ?V?3. It is capable of modulating TGF-? signaling and can be utilized in research related to diabetic nephropathy.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
